Series A - GDMC

Series A - GDMC

Investment Firm

Overview

GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.

Announced Date

Jan 24, 2024

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Celadon Partners

Celadon Partners

Celadon Partners is a private_equity and venture firm.

Participant Investors

3

Investor Name
Participant InvestorNSG Ventures
Participant InvestorCeladon Partners
Participant InvestorWI Harper Group

Round Details and Background

GDMC raised $21000000 on 2024-01-24 in Series A

GDMC is a pharmaceutical company that engages in manufacturing and designing genetic medicines.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 24, 2024
Series A - GDMC
4-21.0M

Recent Activity

There is no recent news or activity for this profile.